Respiratory, Lung Cancer Death Up Even With Low-Intensity Smoking
Current low-intensity smokers have an increased risk for respiratory and lung cancer mortality.
Cancer
European Myeloma Network Provides Vaccine Recommendations for MM
Patients with myeloma should receive 2 doses of the trivalent or quadrivalent vaccine influenza vaccine and vaccinations should continue annually.
CLL Diagnosis Preceded by Decades of Increased Infection Susceptibility
Infections often precede a formal diagnosis of CLL. Researchers found that antimicrobial use began to rise 6 years prior to CLL diagnosis.
Increased Risk of Mycobacterial Infection With Immune Checkpoint Inhibitors
Using FAERS, study researchers identified reported cases of tuberculosis and atypical mycobacterial infection in patients who received ICIs.
Understanding the Oncogenic Role of HIV in Burkitt Lymphoma
While the rate of certain HIV-linked non-Hodgkin lymphomas has declined since the introduction of ART, the incidence of Burkitt lymphoma has remained steady.
Gardasil 9 for the Prevention of Some Head and Neck Cancers: Measuring the Benefit
The approval is based on evidence that the vaccine can prevent anogenital infections, with an ongoing trial looking at throat infection prevention in men likely to be critical for continued approval.
A Call to Investigate IL-17 as Drug Target for Lung Cancer, COVID-19
Interleukin 17 may be a therapeutic target worth investigating for patients with lung cancer and SARS-CoV-2 infection, existing literature suggests.
Hepatocellular Carcinoma Prediction Beyond Year 5 of Therapy in Chronic Hepatitis B
A study identifies risk factors for hepatocellular carcinoma (HCC) after the first 5 years of receiving antiviral therapy in white patients with chronic hepatitis B.
Harnessing Key Elements of the Ebola Virus in Animal Models of Glioblastoma
A glycoprotein in Ebola called the mucin-like domain may be of interest in the development of an oncolytic for brain cancer.
Mortality Risk Among Patients With Oropharynx Cancer Varies Based on HPV Status
For patients with oropharynx cancer, the rates of head and neck cancer mortality and competing mortality vary depending on HPV status.
-
Loading...
-
Loading...
Next post in Prevention
